The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients.

The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients.

This study aims to precise the impact of HIV infection treatment on morbidity and mortality, the factors related to treatment response, clinical and biological complications, their consequences, especially lipodystrophy and metabolic abnormalities, associated factors especially genetic, aspects linked to aging.

In addition, the study describes the evolution of patients living conditions and behaviors remotely from their screening, particularly related to sexuality, reproduction, and health inequalities and to study the long-term treatment adherence.

One third of the patients were included in the metabolic disorders module. This module includes additional biological and imaging explorations.

Inclusion Criteria:

• Patients infected with HIV-1, with a recent diagnosis (<1 year before enrollment)
• Untreated at the time of enrollment,
• Aged 15 or more
• Agreeing to participate in the cohort.

Exclusion Criteria:

• Under protection(saving) of justice

Patients infected with HIV-1, with a recent diagnosis (<1 year before enrollment) and untreated at the time of enrollment, aged 15 or more and agreeing to participate in the cohort.